Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

14,806 recalls, newest first

Class III · Low risk

Theraflu Warming Relief

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing

Terminated Impurity / degradation Novartis Consumer Health NDC 0067-6438-08 D-742-2014
Class III · Low risk

Maximum Strength Comtrex

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.

Terminated Impurity / degradation Novartis Consumer Health NDC 0067-2081-24 D-741-2014
Class III · Low risk

Maximum Strength Comtrex

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.

Terminated Impurity / degradation Novartis Consumer Health NDC 0067-2084-24 D-740-2014
Class II · Moderate risk

Proplete 45 - 51 KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-592-2013
Class II · Moderate risk

Proplete 90+ KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-591-2013
Class II · Moderate risk

Proplete 80+ KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-590-2013
Class II · Moderate risk

Proplete 70+ KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions

Terminated Sterility / contamination Pentec Health D-589-2013
Class II · Moderate risk

Proplete 60 - 69 KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-588-2013
Class II · Moderate risk

Proplete 52 - 59 KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-587-2013
Class II · Moderate risk

Proplete 40 - 44 KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-586-2013
Class II · Moderate risk

Idpn

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-585-2013
Class II · Moderate risk

Proplete 34 - 39 KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-581-2013
Class III · Low risk

Budesonide Capsules

Failed Dissolution Specifications: Routine stability testing at the 12-month interval yielded an out-of-specification (OOS) result for dissolution testing.

Terminated Dissolution failure Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-020-03 D-452-2013
Class I · High risk

Warfarin Sodium Tablets

Failed Tablet/Capsule Specifications: A product complaint was received from a pharmacist who discovered that 3 tablets in a 1000-count bottle were oversized.

Terminated Failed specification Zydus Pharmaceuticals USA Inc NDC 68382-053-10 D-838-2013

Recalls by year